- 51-200 Employees
- Based in Bridgewater, New Jersey
Insmed Incorporated, a biopharmaceutical company, focuses on developing and commercializing inhaled therapies for patients with serious lung diseases. Its lead product candidate is ARIKAYCE, an inhaled antibiotic treatment that delivers an anti-infective directly to the site of serious lung infections.
REPORT RATINGS4.8 / 5.0 (156)
Insmed Incorporated reports have an aggregate usefulness score of 4.8 based on 156 reviews.
Most Recent Annual Report
2022 Annual Report and Form 10K
Insmed Incorporated does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.
Please fill out the form below and click "Place Order" to complete your order.
Older/Archived Annual Reports